Regional neuronal activity in patients with relapsing remitting multiple sclerosis.
Saved in:
| Title: | Regional neuronal activity in patients with relapsing remitting multiple sclerosis. |
|---|---|
| Authors: | Baumgartner, Annette, Frings, Lars, Schiller, Florian, Stich, Oliver, Mix, Michael, Egger, Karl, Schluh, Gisa, Rauer, Sebastian, Meyer, Philipp T. |
| Source: | Acta Neurologica Scandinavica. Dec2018, Vol. 138 Issue 6, p466-474. 9p. |
| Subjects: | Multiple sclerosis, Positron emission tomography, Glucose metabolism, Neuropsychology, Mental depression |
| Abstract: | Objectives: Although interferon‐beta is an established drug for relapsing remitting multiple sclerosis (RRMS), its impact on neuronal activity is not well understood. Methods: We investigated 15 patients with RRMS by [18F]fluorodeoxyglucose positron emission tomography (FDG‐PET) to assess cerebral metabolic rate of glucose (CMRglc) before interferon‐beta therapy. Further, we performed clinical and neuropsychological investigations. In nine patients, these investigations were repeated after 6 months of therapy. Ten healthy controls were also studied. Results: We found no significant differences in absolute CMRglc between patients and controls, or in patients before and during treatment. However, during treatment, relative regional glucose metabolism (rCMRlglc) was decreased in cerebellum and increased in parts of left inferior parietal, temporo‐occipital, frontal cortical areas, left striatum and right insula. In untreated patients, higher fatigue was associated with lower rCMRlglc in portions of left posterior cingulate cortex, and higher depression was associated with lower rCMRlglc within the left superior temporal sulcus. In the pooled sample, higher depression was associated with higher rCMRlglc in parts of the right precuneus. Conclusions: Our results indicate effects of IFN‐beta treatment on cerebellar, cortical and subcortical neuronal function. Moreover, more severe fatigue and depression in untreated patients seem to be associated with reduced neuronal activity in left posterior cingulate cortex and left superior temporal cortex, respectively. [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Neurologica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Objectives: Although interferon‐beta is an established drug for relapsing remitting multiple sclerosis (RRMS), its impact on neuronal activity is not well understood. Methods: We investigated 15 patients with RRMS by [18F]fluorodeoxyglucose positron emission tomography (FDG‐PET) to assess cerebral metabolic rate of glucose (CMRglc) before interferon‐beta therapy. Further, we performed clinical and neuropsychological investigations. In nine patients, these investigations were repeated after 6 months of therapy. Ten healthy controls were also studied. Results: We found no significant differences in absolute CMRglc between patients and controls, or in patients before and during treatment. However, during treatment, relative regional glucose metabolism (rCMRlglc) was decreased in cerebellum and increased in parts of left inferior parietal, temporo‐occipital, frontal cortical areas, left striatum and right insula. In untreated patients, higher fatigue was associated with lower rCMRlglc in portions of left posterior cingulate cortex, and higher depression was associated with lower rCMRlglc within the left superior temporal sulcus. In the pooled sample, higher depression was associated with higher rCMRlglc in parts of the right precuneus. Conclusions: Our results indicate effects of IFN‐beta treatment on cerebellar, cortical and subcortical neuronal function. Moreover, more severe fatigue and depression in untreated patients seem to be associated with reduced neuronal activity in left posterior cingulate cortex and left superior temporal cortex, respectively. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00016314 |
| DOI: | 10.1111/ane.13012 |
